Correlation analysis with AT8 tau pathology revealed higher H4R3me2a levels in the EC region of PART patients compared to AD, with a positive correlation to tau phosphorylation level, suggesting that PRMT3‐mediated H4R3me2a is strongly associated with tau hyperphosphorylation in PART (Figure 4I,J). This evidence concerns the gene MAPT and Alzheimer disease.